| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 15 | |
| #2 | WIPO (World Intellectual Property Organization) | 11 | |
| #3 | China | 5 | |
| #4 | EPO (European Patent Office) | 4 | |
| #5 | Japan | 4 | |
| #6 | Canada | 3 | |
| #7 | United States | 3 | |
| #8 | Republic of Korea | 2 | |
| #9 | Brazil | 1 | |
| #10 | Israel | 1 | |
| #11 | India | 1 | |
| #12 | Mexico | 1 | |
| #13 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Organic fine chemistry | |
| #5 | Foods and drinks | |
| #6 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Micklem David Robert | 15 |
| #2 | Nilsson Linn Hodneland | 12 |
| #3 | Ahmed Lavina | 8 |
| #4 | Kiprijanov Sergej | 8 |
| #5 | Haugen Hallvard | 8 |
| #6 | Tiron Crina | 6 |
| #7 | Lorens Jim | 6 |
| #8 | Petersen Lene Raunkjaer | 4 |
| #9 | Hellesoy Monica | 4 |
| #10 | Naylor Alan | 3 |
| Publication | Filing date | Title |
|---|---|---|
| GB202004189D0 | Combination therapy | |
| GB201912059D0 | Combaination therapy of a patient subgroup | |
| GB201807789D0 | Serum biomarkers | |
| GB201519919D0 | Pharmaceutically active compounds | |
| GB201512133D0 | Biomarkers | |
| GB201509338D0 | Combination therapy | |
| GB201508787D0 | Pharmaceutically active compounds | |
| GB201506411D0 | Humanized anti-axl antibodies | |
| US2016339021A1 | Use of kinase inhibitors | |
| GB201420239D0 | Biomarker | |
| GB201420285D0 | Process | |
| GB201410826D0 | Anti-axl antibodies | |
| GB201410825D0 | Anti-axl antibodies | |
| GB201321227D0 | Use of kinase inhibitors | |
| GB201207722D0 | Method |